$FBRT
Franklin BSP Realty Trust, Inc.

2013 Q2 Form 10-Q Financial Statement

#000156252813000004 Filed on August 13, 2013

View on sec.gov

Income Statement

Concept 2013 Q2
Revenue $57.32K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $197.5K
YoY Change
Operating Profit
YoY Change
Interest Expense $8.756K
YoY Change
% of Operating Profit
Other Income/Expense, Net $55.00K
YoY Change
Pretax Income -$140.1K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$140.1K
YoY Change
Net Earnings / Revenue -244.47%
Basic Earnings Per Share -$1.37
Diluted Earnings Per Share -$1.37
COMMON SHARES
Basic Shares Outstanding 102.0K shares
Diluted Shares Outstanding 102.0K shares

Balance Sheet

Concept 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $204.3K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $4.242M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $4.201M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$179.5K
YoY Change
Common Stock $1.106K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.43K
YoY Change
Total Liabilities & Shareholders Equity $4.242M
YoY Change

Cashflow Statement

Concept 2013 Q2
OPERATING ACTIVITIES
Net Income -$140.1K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
ck1562528 Board Expenses
BoardExpenses
81429 USD
CY2013Q2 ck1562528 Board Expenses
BoardExpenses
81429 USD
CY2013Q2 ck1562528 Common Stock Dividends Per Share Per Day Declared
CommonStockDividendsPerSharePerDayDeclared
0.00565068493
ck1562528 Common Stock Issued Dividend Reinvestment Investment Plan
CommonStockIssuedDividendReinvestmentInvestmentPlan
526 USD
ck1562528 Distribution Percentage Requiredto Avoid Paying Federal Income Taxes
DistributionPercentageRequiredtoAvoidPayingFederalIncomeTaxes
1
ck1562528 Intentional Maximum Sale Of Stock
IntentionalMaximumSaleOfStock
2000000000 USD
CY2013Q2 ck1562528 Loan Receivable Acquisition Feesand Expenses
LoanReceivableAcquisitionFeesandExpenses
60000 USD
CY2013Q2 ck1562528 Loans Receivable Current Face Amount
LoansReceivableCurrentFaceAmount
6494000 USD
CY2013Q2 ck1562528 Loans Receivable Discount
LoansReceivableDiscount
2515000 USD
CY2013Q2 ck1562528 Loans Receivable Gross Credit Loans
LoansReceivableGrossCreditLoans
3979467 USD
CY2012Q4 ck1562528 Loans Receivable Gross Credit Loans
LoansReceivableGrossCreditLoans
0 USD
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
970329 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
635216 USD
CY2013Q2 ck1562528 Loans Receivable Original Face Amount
LoansReceivableOriginalFaceAmount
6500000 USD
ck1562528 Maximum Percentage Of Shares Authorized To Repurchase During Year
MaximumPercentageOfSharesAuthorizedToRepurchaseDuringYear
0.05
ck1562528 Minimum Distribution Percentageto Qualifyfor Reit Taxation Status
MinimumDistributionPercentagetoQualifyforREITTaxationStatus
0.9
CY2013Q2 ck1562528 Numberof Impaired Loan Receivables
NumberofImpairedLoanReceivables
0 loan
ck1562528 Organizationaland Offering Costs Maximum Excluding Commissionsand Dealer Manager Fees
OrganizationalandOfferingCostsMaximumExcludingCommissionsandDealerManagerFees
0.02
ck1562528 Reclassification Of Deferred Offering Costs
ReclassificationOfDeferredOfferingCosts
940618 USD
ck1562528 Revenue Recognition Periodat Which Revenue Recognitionis Suspended
RevenueRecognitionPeriodatWhichRevenueRecognitionisSuspended
P90D
CY2013Q2 ck1562528 Saleof Stock Minimum Amountto Release Proceeds
SaleofStockMinimumAmounttoReleaseProceeds
2000000 USD
ck1562528 Short Term Trading Fee Percentage
ShortTermTradingFeePercentage
0.02
CY2013Q2 ck1562528 Stock Repurchase Program Numberof Shares Eligibletobe Repurchased
StockRepurchaseProgramNumberofSharesEligibletobeRepurchased
0 shares
ck1562528 Weighted Average Risk Ratingof Loans
WeightedAverageRiskRatingofLoans
2.0 rating
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
19733 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
218792 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
199911 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2288932 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4089 shares
CY2012Q4 us-gaap Assets
Assets
941191 USD
CY2013Q2 us-gaap Assets
Assets
4241560 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204309 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
573 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
203736 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110610 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8888 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8888 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110610 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114609 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
89 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
1106 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-145151 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140132 USD
CY2012Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
940618 USD
CY2013Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0 USD
us-gaap Dividends
Dividends
18789 USD
CY2012Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2013Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
17755 USD
CY2012Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
121500 USD
CY2013Q2 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
1255056 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.42
us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
17755 USD
us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
5500 USD
us-gaap General Insurance Expense
GeneralInsuranceExpense
55000 USD
CY2013Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
55000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
129441 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
24631 USD
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
1133556 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7987 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
33153 USD
CY2013Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
66076 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
66077 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
8756 USD
us-gaap Interest Expense
InterestExpense
8756 USD
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 USD
CY2013Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7987 USD
CY2012Q4 us-gaap Interest Receivable
InterestReceivable
0 USD
CY2013Q2 us-gaap Interest Receivable
InterestReceivable
24631 USD
CY2012Q4 us-gaap Liabilities
Liabilities
756716 USD
CY2013Q2 us-gaap Liabilities
Liabilities
4201127 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
941191 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4241560 USD
CY2013Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
0 USD
CY2012Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
0 USD
CY2013Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3979467 USD
CY2012Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
0 USD
CY2013Q2 us-gaap Loans Receivable Net
LoansReceivableNet
3979467 USD
CY2012Q4 us-gaap Loans Receivable Net
LoansReceivableNet
0 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
0 USD
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
1950000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4241907 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3959735 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78436 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-140132 USD
us-gaap Net Income Loss
NetIncomeLoss
-145151 USD
us-gaap Operating Expenses
OperatingExpenses
202472 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
197452 USD
CY2013Q2 us-gaap Other Expenses
OtherExpenses
42934 USD
us-gaap Other Expenses
OtherExpenses
47954 USD
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-6179 USD
CY2013Q2 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-6179 USD
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
507 USD
CY2013Q2 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
1034 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1142642 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
0 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
33153 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
1950000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2301500 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2500000 USD
us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
-3965914 USD
us-gaap Professional Fees
ProfessionalFees
18089 USD
CY2013Q2 us-gaap Professional Fees
ProfessionalFees
18089 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15525 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179465 USD
CY2013Q2 us-gaap Revenues
Revenues
57320 USD
us-gaap Revenues
Revenues
57321 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6804 USD
CY2013Q2 us-gaap Share Price
SharePrice
25.00
dei Entity Central Index Key
EntityCentralIndexKey
0001562528
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
203560 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
22 shares
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
526 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
2765232 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2301500 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6804 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
40433 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
184475 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
184475 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40433 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
25.00
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;text-indent:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding classification of investments, fair value measurements, credit losses and impairments of investments, and derivative financial instruments and hedging activities, as applicable. </font></div></div>
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
101990 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
101990 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
99897 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
ARC Realty Finance Trust, Inc.

Files In Submission

Name View Source Status
0001562528-13-000004-index-headers.html Edgar Link pending
0001562528-13-000004-index.html Edgar Link pending
0001562528-13-000004.txt Edgar Link pending
0001562528-13-000004-xbrl.zip Edgar Link pending
arcrft-20130630x10q.htm Edgar Link pending
arcrft-20130630x10qex107.htm Edgar Link pending
arcrft-20130630x10qex108.htm Edgar Link pending
ck1562528-20130630.xml Edgar Link completed
ck1562528-20130630.xsd Edgar Link pending
ck1562528-20130630_cal.xml Edgar Link unprocessable
ck1562528-20130630_def.xml Edgar Link unprocessable
ck1562528-20130630_lab.xml Edgar Link unprocessable
ck1562528-20130630_pre.xml Edgar Link unprocessable
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
secondamendedandrestatedsu.htm Edgar Link pending
Show.js Edgar Link pending